Pritchard Michele T, McMullen Megan R, Stavitsky Abram B, Cohen Jessica I, Lin Feng, Edward Medof M, Nagy Laura E
Department of Nutrition, Case Western Reserve University, Cleveland, OH 44106-4906.
Pathology, Western Reserve University, Case Cleveland, OH 44106-4906.
Gastroenterology. 2007 Mar;132(3):1117-1126. doi: 10.1053/j.gastro.2007.01.053. Epub 2007 Feb 1.
The complement pathway is an important component of the innate and adaptive immune response. Here we tested the hypothesis that activation of complement is required for development of ethanol-induced fatty liver.
Wild-type mice and mice lacking the third (C3) or fifth (C5) components of the complement activation pathway, as well as mice lacking decay-accelerating factor (CD55/DAF), a complement regulatory protein, were fed Lieber-DeCarli ethanol-containing diets for 6 weeks or pair-fed control diets.
Ethanol feeding to wild-type mice increased C3a in plasma. Wild-type and C5-/- mice fed the ethanol diet developed hepatic steatosis characterized by microvesicular and macrovesicular lipid accumulation and increased triglyceride content. C3-/- mice did not develop steatosis, while CD55/DAF-/- mice accumulated even more hepatic triglyceride after ethanol feeding than wild-type mice. Levels of serum alanine aminotransferase and hepatic tumor necrosis factor alpha, indicators of hepatocyte injury and inflammation, respectively, were increased in wild-type and CD55/DAF-/- mice but not in C5-/- mice after ethanol feeding. In contrast to the protective effect of C3-/- against ethanol-induced steatosis, levels of both alanine aminotransferase and tumor necrosis factor alpha were increased in C3-/- mice after ethanol feeding.
Here we have identified several elements of the complement system as important contributors to ethanol-induced fatty liver. C3 contributed primarily to the accumulation of triglyceride in the liver, whereas C5 was involved in inflammation and injury to hepatocytes. Further, the absence of CD55/DAF exacerbated these responses, suggesting that CD55/DAF serves as a barrier to ethanol-induced fatty liver.
补体途径是先天性和适应性免疫反应的重要组成部分。在此,我们检验了补体激活是乙醇诱导脂肪肝发生所必需的这一假说。
将野生型小鼠、缺乏补体激活途径第三(C3)或第五(C5)成分的小鼠,以及缺乏补体调节蛋白衰变加速因子(CD55/DAF)的小鼠,喂食含Lieber-DeCarli乙醇的饲料6周,或给予配对的对照饲料。
给野生型小鼠喂食乙醇会增加血浆中的C3a。喂食乙醇饲料的野生型和C5-/-小鼠出现了肝脂肪变性,其特征为微泡和大泡性脂质蓄积以及甘油三酯含量增加。C3-/-小鼠未发生脂肪变性,而CD55/DAF-/-小鼠在喂食乙醇后肝脏甘油三酯的蓄积比野生型小鼠更多。喂食乙醇后,野生型和CD55/DAF-/-小鼠血清丙氨酸氨基转移酶水平以及肝细胞损伤和炎症指标肝肿瘤坏死因子α水平升高,但C5-/-小鼠未升高。与C3-/-对乙醇诱导脂肪变性的保护作用相反,喂食乙醇后C3-/-小鼠的丙氨酸氨基转移酶和肿瘤坏死因子α水平均升高。
在此,我们确定了补体系统的几个要素是乙醇诱导脂肪肝的重要促成因素。C3主要促成肝脏甘油三酯的蓄积,而C5参与肝细胞的炎症和损伤。此外,CD55/DAF的缺失加剧了这些反应,表明CD55/DAF是乙醇诱导脂肪肝的一道屏障。